Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to DE1950SC002359priorityCriticalpatent/DE1615974U/en
Publication of DE1615974UpublicationCriticalpatent/DE1615974U/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Description
u. u. uall-a--A. 2OzroSftllMt... 1 UBe-f24*bAm an Ofr*mMvhenqtuwbmuiMM4aswtK&. sjMM<MSaw= m pwfaeea <s ßßMMm$Maa ? aeiBN&esBB$ seaBMase. .81e..., . 18t. tn 8o1t.. 1~--. ----. au. 1- Ua-- 1d.. . Ge -. oa 1- Wftleta.. 18'.Der oben ftU : 8pftact ! Ja --... T18ñd "'1'. C WfI. 10. -. J1e D8et1.. ---- ti~blech. Ia4- aaIen h11 1at.. 14ne1*1a fßtt'ftn. 81uebet*1Hm ab Ska11" 81. 8Jabo1- a.. -IhM alaht-M-. S&tsB<a&a$$s Msf as ss esMiaMaMBF'pttß'wpt.aHMrbMFKNaMgßN&wtaaN M) <miKeei<e88aw<asarton «<<wNMgi . Mw aHtäMMaKtMtMiHMaMMW <t<MMaaa 8ei egmor4on 4"soilq, aet stout 41, mm K*n*tvt*t : toa AAUOmotdt"tJKe MM uu u all-a - A. 2 OzroSftllMt ... 1 UBe -f24 * bAm an Ofr * mMvhen qtuwbmu iMM4aswtK &. sjMM <MSaw = m pw faeea <s ßßMMm $ Maa? aeiBN & esB B $ seaBMase . . 81e ...,. 18t. tn 8o1t .. 1 ~ - -. ----. ouch 1- Ua- - 1d ... Ge -. oa 1- Wftleta .. 18 '. The above ftU: 8pftact! Yes --... T18ñd "'1'. C WfI . 10. -. J1e D8et1 .. ---- ti ~ sheet. Yes 4- aaIen h11 1at .. 14ne1 * 1a fßtt'ftn. 81uebet * 1Hm from Ska11 "81. 8Jabo1- a .. -IhM alaht- M. - . S & tsB <a & a $$ s Msf as ss esMiaMaMBF'pt tß'wpt. aHMrbMFKNaMgßN & wtaaN M) <m iKeei <e88aw <asart on « << wNMgi. Mw aHtäMMa KtMtMiHMaMMW <t <MMaaa 8 ei eg mor4on 4 "soilq, aet stout 41, mm K * n * tvt * t: toa AAUO motdt "t JKe MM
Claims (1)
'''',, < ao*''''.,, tWhrnl '<. /' *-nchyct<.SW/S&m&s d amzie- ä af ser <xl$'beno G,,/jMi ! jR$ 'MlMMn Sie se'aa'<<< Mp&MiMtMaaa Tmarmier -'.. -m iy Ba<t$<'<& Ml M sgr&e.
'''' ,, <ao * ''''. ,, tWhrnl '<. / '* -nchyct <. SW / S & m & s d amzie- ä af ser <xl $ ' beno G ,, / jMi! jR $ 'MlMMn you se'aa '<<< Mp & MiMtMaaa Tmarmier -' .. -m iy Ba <t $ <'<& Ml M sgr & e.
2,4-DIAMINO-5- (4'-HYDROXYBENZYL) PYRIMIDINES FOR USE, AS A STARTING MATERIAL FOR THE PREPARATION OF 2,4-DIAMINO-5- (3 ', 4', 5'-TRIALICOCIBENSYL) PYRIMIDINES